Acute Hepatic Porphyria (AHP)

International Congress of Inborn Errors Metabolism (ICIEM) 2025

Congress Details

2-6 September 2025 | Japan

Kyoto, Japan

The materials in this section are intended for UK healthcare professionals and include scientific and educational congress content related to givosiran▼. The information contained in these presentations and posters was accurate at the time of presentation. Healthcare professionals should consult the current full Prescribing Information [for the most up-to-date information on indications, dosing, contraindications, warnings, and adverse reactions].

Congress Materials

Presentation Type

Presentation

Location

Kyoto, Japan

Title

Long-term clinical outcomes of patients with acute hepatic porphyria who were not attack-free after 6 months of givosiran treatment in a subgroup analysis of the phase 3 ENVISION study

Access Prescribing Information